Revenue $2.04B, up 15.0% on a year earlier. EIG Sales $1.32B, up 13.9%. EMG Sales $723.24M, up 16.9%. Diluted EPS $1.77 against $1.55.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.04B | $1.93B | $1.78B | +15.0% |
| Operating income | $528.19M | $514.94M | $461.63M | +14.4% |
| Net income | $406.90M | $399.36M | $358.37M | +13.5% |
| Diluted EPS | $1.77 | $1.74 | $1.55 | |
| Operating cash flow | $483.69M | $451.52M | $359.09M | +34.7% |
| Capital expenditures | -$32.01M | -$25.47M | -$29.27M | |
| Free cash flow | $451.68M | $426.05M | $329.82M | +36.9% |
| Dividend per share | $0.34 | $0.34 | $0.31 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| EIG Sales | $1.32B | $1.16B | +13.9% |
| EMG Sales | $723.24M | $618.50M | +16.9% |
| Net sales growth | 15% | 2.49% |
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| Q2 FY26 | Diluted EPS | $1.96 to $2.00 | $1.77 | below |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Ametek (AME) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/AME/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
